222 related articles for article (PubMed ID: 12210228)
1. Apolipoprotein E and other cerebrospinal fluid proteins differentiate ante mortem variant Creutzfeldt-Jakob disease from ante mortem sporadic Creutzfeldt-Jakob disease.
Choe LH; Green A; Knight RS; Thompson EJ; Lee KH
Electrophoresis; 2002 Jul; 23(14):2242-6. PubMed ID: 12210228
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease.
Brechlin P; Jahn O; Steinacker P; Cepek L; Kratzin H; Lehnert S; Jesse S; Mollenhauer B; Kretzschmar HA; Wiltfang J; Otto M
Proteomics; 2008 Oct; 8(20):4357-66. PubMed ID: 18814332
[TBL] [Abstract][Full Text] [Related]
3. Creutzfeldt-Jakob disease: diagnostic utility of 14-3-3 protein immunodetection in cerebrospinal fluid.
Collins S; Boyd A; Fletcher A; Gonzales M; McLean CA; Byron K; Masters CL
J Clin Neurosci; 2000 May; 7(3):203-8. PubMed ID: 10833616
[TBL] [Abstract][Full Text] [Related]
4. Studies of potential cerebrospinal fluid molecular markers for Alzheimer's disease.
Choe LH; Dutt MJ; Relkin N; Lee KH
Electrophoresis; 2002 Jul; 23(14):2247-51. PubMed ID: 12210229
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease.
Van Everbroeck B; Boons J; Cras P
Clin Neurol Neurosurg; 2005 Aug; 107(5):355-60. PubMed ID: 16023527
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis of the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.
Cepek L; Brechlin P; Steinacker P; Mollenhauer B; Klingebiel E; Bibl M; Kretzschmar HA; Wiltfang J; Otto M
Dement Geriatr Cogn Disord; 2007; 23(1):22-8. PubMed ID: 17068393
[TBL] [Abstract][Full Text] [Related]
7. [CSF-analyses in clinical diagnosis of Creutzfeldt-Jakob disease. A literature review and three cases from routine clinical practice].
Blennow K; Lind B; Andersson E; Andreasen N
Lakartidningen; 2001 May; 98(20):2446-51. PubMed ID: 11433975
[TBL] [Abstract][Full Text] [Related]
8. Abnormal proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.
Harrington MG; Merril CR; Asher DM; Gajdusek DC
N Engl J Med; 1986 Jul; 315(5):279-83. PubMed ID: 3523251
[TBL] [Abstract][Full Text] [Related]
9. [Clinical algorithm for cerebrospinal fluid test of 14-3-3 protein in diagnosis of Creutzfeldt-Jacob disease].
Lemstra AW; van Meegen M; Baas F; van Gool WA
Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1467-71. PubMed ID: 11503317
[TBL] [Abstract][Full Text] [Related]
10. Searching for markers of Creutzfeldt-Jakob disease in cerebrospinal fluid by two-dimensional mapping.
Piubelli C; Fiorini M; Zanusso G; Milli A; Fasoli E; Monaco S; Righetti PG
Proteomics; 2006 Apr; 6 Suppl 1():S256-61. PubMed ID: 16511811
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin as potential cerebrospinal fluid marker of Creutzfeldt-Jakob disease.
Steinacker P; Rist W; Swiatek-de-Lange M; Lehnert S; Jesse S; Pabst A; Tumani H; von Arnim CA; Mitrova E; Kretzschmar HA; Lenter M; Wiltfang J; Otto M
Proteomics; 2010 Jan; 10(1):81-9. PubMed ID: 19882659
[TBL] [Abstract][Full Text] [Related]
12. The role of cerebrospinal fluid proteins as early diagnostic markers for sporadic Creutzfeldt-Jakob disease.
Pennington C; Chohan G; Mackenzie J; Andrews M; Will R; Knight R; Green A
Neurosci Lett; 2009 May; 455(1):56-9. PubMed ID: 19429106
[TBL] [Abstract][Full Text] [Related]
13. Beta-amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.
Wiltfang J; Esselmann H; Smirnov A; Bibl M; Cepek L; Steinacker P; Mollenhauer B; Buerger K; Hampel H; Paul S; Neumann M; Maler M; Zerr I; Kornhuber J; Kretzschmar HA; Poser S; Otto M
Ann Neurol; 2003 Aug; 54(2):263-7. PubMed ID: 12891683
[TBL] [Abstract][Full Text] [Related]
14. 14-3-3 in the cerebrospinal fluid of patients with variant and sporadic Creutzfeldt-Jakob disease measured using capture assay able to detect low levels of 14-3-3 protein.
Green AJ; Ramljak S; Müller WE; Knight RS; Schröder HC
Neurosci Lett; 2002 May; 324(1):57-60. PubMed ID: 11983294
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of Creutzfeldt-Jakob disease by two-dimensional gel electrophoresis of cerebrospinal fluid.
Zerr I; Bodemer M; Otto M; Poser S; Windl O; Kretzschmar HA; Gefeller O; Weber T
Lancet; 1996 Sep; 348(9031):846-9. PubMed ID: 8826809
[TBL] [Abstract][Full Text] [Related]
16. CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease.
Sanchez-Juan P; Green A; Ladogana A; Cuadrado-Corrales N; Sáanchez-Valle R; Mitrováa E; Stoeck K; Sklaviadis T; Kulczycki J; Hess K; Bodemer M; Slivarichová D; Saiz A; Calero M; Ingrosso L; Knight R; Janssens AC; van Duijn CM; Zerr I
Neurology; 2006 Aug; 67(4):637-43. PubMed ID: 16924018
[TBL] [Abstract][Full Text] [Related]
17. Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease.
Geschwind MD; Martindale J; Miller D; DeArmond SJ; Uyehara-Lock J; Gaskin D; Kramer JH; Barbaro NM; Miller BL
Arch Neurol; 2003 Jun; 60(6):813-6. PubMed ID: 12810484
[TBL] [Abstract][Full Text] [Related]
18. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies.
Hsich G; Kenney K; Gibbs CJ; Lee KH; Harrington MG
N Engl J Med; 1996 Sep; 335(13):924-30. PubMed ID: 8782499
[TBL] [Abstract][Full Text] [Related]
19. Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias.
Riemenschneider M; Wagenpfeil S; Vanderstichele H; Otto M; Wiltfang J; Kretzschmar H; Vanmechelen E; Förstl H; Kurz A
Mol Psychiatry; 2003 Mar; 8(3):343-7. PubMed ID: 12660807
[TBL] [Abstract][Full Text] [Related]
20. Dissociation between CSF total tau and tau protein phosphorylated at threonine 231 in Creutzfeldt-Jakob disease.
Buerger K; Otto M; Teipel SJ; Zinkowski R; Blennow K; DeBernardis J; Kerkman D; Schröder J; Schönknecht P; Cepek L; McCulloch C; Möller HJ; Wiltfang J; Kretzschmar H; Hampel H
Neurobiol Aging; 2006 Jan; 27(1):10-5. PubMed ID: 16298235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
